Intellectual Property Law

Patent and Antitrust: Differing Shades of Meaning
Posted by D. Daniel Sokol Robin Cooper Feldman of UC Hastings College of Law discusses Patent and Antitrust: Differing Shades of Meaning in her latest article. ABSTRACT: The relationship between patent law and antitrust law has challenged legal minds since...

Profit Neutrality in Licensing: The Boundary between Antitrust Law and Patent Law
Posted by D. Daniel Sokol Stephen M. Maurer and Suzanne Scotchmer both of Berkeley's Goldman School of Public Policy address Profit Neutrality in Licensing: The Boundary between Antitrust Law and Patent Law...

271Blog discusses patent quality
In a post titled --USPTO Patent Quality - It's Not As Bad As You Think --, the 271blog discusses the recent work by James Malackowski and Jonathan Barney from Ocean Tomo.LBE has been discussing the bogus issues with patent quality for years in papers in JIP, JPTOS, and IPT...

Patent & Antitrust At Duke Law School
On February 29, Duke’s Intellectual Property and Cyberlaw Society and the Duke Law and Technology Review are holding their 7th annual “Hot Topics” Symposium.  The topics this year are patent reform and the intersection between antitrust law and intellectual property...

State Antitrust Lawsuits: A Good Way to Balance Costs and Incentives for Patented Drugs
Posted by D. Daniel Sokol Alexander Okuliar and James P. Kidder of O'Melvany & Meyer have a policy paper for the Washington Legal Foundation titled State Antitrust Lawsuits: A Good Way to Balance Costs and Incentives for Patented Drugs.

PatentCafe Adds New Patent Quality Reports to Its Free CAFC Library
The following is excerpted from a May 28, 2008 PatentCafe press release: The new Patent Factor Index (PFi) Reports, available for public downloading without cost, statistically score more than 2 dozen indicators of patent quality, many of the indices correlating...

Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.

WaMu Cash Balance Pension Plan - Partial Preliminary Settlement
WaMu Cash Balance Pension Plan Partial Preliminary Settlement

Wesley A. Snyder et al.
alleging the consultants perpetrated a Ponzi scheme by encouraging borrowers to lend more than they needed.

Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.

DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Clearwire Service
alleging poor quality and unfairly charging early termination fees.